News
NEW YORK, NY, USA I July 15, 2025 I SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback